galantamine has been researched along with Sensitivity and Specificity in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özdemir, E; Tatar Ulu, S | 1 |
| Mullangi, R; Sukumaran, SK; Suresh, PS | 1 |
| Chen, SH; Hsieh, YH; Lin, PC; Yang, YH; Yeh, HH | 1 |
| An, JJ; Cheng, JF; Jiang, Y; Li, HJ; Li, P; Zhou, JL | 1 |
| Kang, JS; Kim, SH; Kim, SY; Kim, YH; Lee, MH; Park, YS; Shaw, LM; Yang, SC | 1 |
| Caro, JJ; Garfield, FB; Getsios, D; Wimo, A; Winblad, B | 1 |
| Harmon, HJ; Legako, JA; White, BJ | 1 |
| de Jong, J; De Meulder, M; de Vries, R; Diels, L; Verhaeghe, T | 1 |
| Bullock, R; Caro, JJ; Getsios, D; Ishak, K; O'Brien, J; Ward, A | 1 |
| Abramowski, D; De Deyn, PP; Staufenbiel, M; Van Dam, D | 1 |
| Scheltens, P; Verhey, FR; Visser, PJ | 1 |
| Buchta, M; Havlicek, V; Jegorov, A; Kuzma, M; Sedmera, P | 1 |
| Kandikere, VN; Maurya, S; Mudigonda, K; Nirogi, RV | 1 |
| Brückner, A; Cvitkovich, B; Czollner, L; Fröhlich, J; Jordis, U; Kremser, L; Küenburg, B; Rizzi, A; Schuh, R | 1 |
| Bucks, RS; Byrne, LM; Hughes, AO; Wilcock, GK; Wilson, PM | 1 |
1 review(s) available for galantamine and Sensitivity and Specificity
| Article | Year |
|---|---|
Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cost-Benefit Analysis; Drug Costs; Female; Galantamine; Humans; Male; Models, Econometric; Nootropic Agents; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sensitivity and Specificity; United Kingdom | 2003 |
2 trial(s) available for galantamine and Sensitivity and Specificity
| Article | Year |
|---|---|
Quantification of galantamine in human plasma by validated liquid chromatography-tandem mass spectrometry using glimepride as an internal standard: application to bioavailability studies in 32 healthy Korean subjects.
Topics: Adult; Biological Availability; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Cross-Over Studies; Galantamine; Humans; Least-Squares Analysis; Liquid-Liquid Extraction; Male; Reproducibility of Results; Republic of Korea; Sensitivity and Specificity; Sulfonylurea Compounds; Tandem Mass Spectrometry; Therapeutic Equivalency | 2012 |
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Female; Follow-Up Studies; Galantamine; Humans; Lactones; Male; Memory Disorders; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Piracetam; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Sulfones | 2005 |
12 other study(ies) available for galantamine and Sensitivity and Specificity
| Article | Year |
|---|---|
Highly sensitive HPLC method for the determination of galantamine in human plasma and urine through derivatization with dansyl chloride using fluorescence detector.
Topics: Chromatography, High Pressure Liquid; Dansyl Compounds; Fluorescence; Galantamine; Humans; Limit of Detection; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Highly sensitive LC-MS/MS method for determination of galantamine in rat plasma: application to pharmacokinetic studies in rats.
Topics: Animals; Brain Chemistry; Chromatography, Liquid; Drug Stability; Galantamine; Linear Models; Liquid-Liquid Extraction; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Benzylamines; Buffers; Cholinesterase Inhibitors; Chromatography, Micellar Electrokinetic Capillary; Drug Monitoring; Galantamine; Humans; Male; Phenethylamines; Phenols; Phenylcarbamates; Phosphoric Acids; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity; Solvents; Surface-Active Agents | 2009 |
Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Chromatography, Gel; Chromatography, Liquid; Equipment Design; Galantamine; Ligands; Mass Spectrometry; Peptide Library; Protein Binding; Proteins; Reproducibility of Results; Sensitivity and Specificity; Sesquiterpenes; Structure-Activity Relationship | 2009 |
Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Clinical Trials as Topic; Cost of Illness; Disease Progression; Drug Costs; Galantamine; Health Care Costs; Health Services Needs and Demand; Health Services Research; Humans; Institutionalization; Long-Term Care; Models, Econometric; Nootropic Agents; Probability; Sensitivity and Specificity; Sweden | 2002 |
Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase.
Topics: Acetylcholinesterase; Binding, Competitive; Biosensing Techniques; Cholinesterase Inhibitors; Diazinon; Enzymes, Immobilized; Equipment Design; Equipment Failure Analysis; Equipment Reuse; Galantamine; Indicators and Reagents; Octoxynol; Physostigmine; Porphyrins; Quality Control; Reproducibility of Results; Scopolamine; Sensitivity and Specificity; Spectrum Analysis; Tetracaine | 2003 |
Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma.
Topics: Chromatography, High Pressure Liquid; Galantamine; Heparin; Humans; Mass Spectrometry; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Galantamine; Humans; Indans; Male; Memantine; Mice; Mice, Mutant Strains; Phenylcarbamates; Piperidines; Rivastigmine; Sensitivity and Specificity | 2005 |
Accurate product ion mass spectra of galanthamine derivatives.
Topics: Algorithms; Galantamine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2006 |
Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard.
Topics: Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Galantamine; Humans; Loratadine; Reference Standards; Sensitivity and Specificity; Tandem Mass Spectrometry; Therapeutic Equivalency | 2007 |
Enantiomeric resolution of galanthamine and related drugs used in anti-Alzheimer therapy by means of capillary zone electrophoresis employing derivatized cyclodextrin selectors.
Topics: Alzheimer Disease; Electrophoresis, Capillary; Galantamine; Galanthus; Humans; Nootropic Agents; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 1999 |
The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Clinical Trials as Topic; Female; Galantamine; Humans; Male; Mental Status Schedule; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sensitivity and Specificity; Tacrine | 2000 |